Zelig Eshhar is an Israeli immunologist at the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center. He was Chairman of the Department of Immunology at the Weizmann Institute twice, in the 1990s and 2000s.
ZeligEshhar is an Israeli immunologist at the Weizmann Institute of Science and the Tel Aviv Sourasky Medical Center. He was Chairman of the Department...
Gross is an Israeli immunologist, inventor and farmer. Together with ZeligEshhar at the Weizmann Institute of Science, they created the first chimeric...
Pascal Mayer, Shankar Balasubramanian, David Klenerman, Michel Sadelain, ZeligEshhar Canada Gairdner Global Health Award Canada Gairdner Wightman Award List...
Kogyo, Co. Ltd. in Japan, and independently in 1989 by Gideon Gross and ZeligEshhar at the Weizmann Institute in Israel. Originally termed "T-bodies", these...
Alison Bashford, Katharine Park, Keith Wailoo Present – Public Health Anthony Fauci Future – Molecular Medicine ZeligEshhar, Carl June, Steven Rosenberg...
engineering Professor Jacob Ziv Life Sciences Cancer Research Professor ZeligEshhar and Professor Alexander Levitzki Social Sciences Economics Professor...
D. in immunology from the Weizmann Institute of Science, advised by ZeligEshhar, after developing the Chimeric Antigen Receptor Regulatory T cell (CAR-Treg)...
molecular mechanisms of intracellular motility 2014 Steven Rosenberg, ZeligEshhar and James P. Allison for their research on T cells. 2015 Philippe Horvath...
Harold Zvi Schiffrin East Asian studies Shmuel Ahituv Biblical studies ZeligEshhar Life sciences 2016 Meir Lahav Chemistry & Physics Leslie Leiserowitz...
Lafferty [Wikidata], Avrion Mitchison, David Talmage 1992 Jack Strominger 2016 ZeligEshhar, Carl June, Steven Rosenberg 2013 James Allison 2010 Charles Dinarello...
career Fields Biochemistry Evolution Molecular biology Institutions Weizmann Institute of Science Doctoral advisor Profs. ZeligEshhar and Michael Sela...
of CD8+ and CD4+ T cells with few major contaminating cells. In 1989 ZeligEshhar published the first study in which a T cell's targeting receptor was...